The usability of search within IRT is enhanced

NEWS
Press-Release
Software
April 6, 2023

[Limassol – 06.04.2023] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches Immune Response Template (IRT) version 3.6.2. IRT update focuses on usability and efficiency of search for information on the platform. Previously, the content was adapted for QSP projects in Oncology development (IRT Onco version).

IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system. Initially, IRT is based on two main components. On the one hand, it is a fully-fledged database including a wide variety of features covering the immune system. On the other hand, it comprises Navigator that provides intuitive interface to interact with IRT Database. Thus, a modeler can apply calibrated sub-models exported from IRT as building blocks to simplify the model development process.

IRT is a part of InSysBio’s QSP software infrastructure being under constant upgrade. The users’ convenience is now enhanced by the new annotation style. The text that contains detailed information on parameters is available directly in the right panel. Each parameter now has its own personal tag that allows to find a detailed description of the value source. 

The identifications types were redefined:

  • Calculated. The parameters are calculated directly from in vitro experimental data with derived formulas.
  • Fitted. The supplementary models were developed for in vitro or in vivo experiment description. The parameters’ values were fitted against the data from the described experiment. The supplementary models’ description and additional information are attached to the parameters’ annotations.
  • Taken. The parameters were taken directly from the open source.
  • Arbitrary. These parameters are different for each specific model.
  • Assumed. The parameter’s value is assumed. The reasoning of an assumption is described in the annotation file attached to the parameter value.
  • Not_identified. This parameter was not identified in the current version of the database.

The description of the calculated parameters contains a direct link to the article about an in vitro experiment. Formulas used in parameter calculation may be found in the supplementary annotation files. The description of the fitted parameters now includes files that cover the fitting process and links to the open-source data. Additionally, the display of values has also been modified. They have been shortened and rounded for the ease of use. 

Veronika Musatova, Head of IRT development team, comments on the new version, “This update will help users to quickly and easily find the links to the data used for parameters identification. Moreover, files of the models exported from IRT will also include this information after the update”.

Furthermore, the demo version of IRT has been also updated. Two sub models are now available in the demo version: IL6 and Neutrophils. The information on parameters is displayed in the same way as in the full IRT version. 

To learn the full content of Immune Response Template, please visit irt.insysbio.com.

To get demo access to IRT, please click “sign in” or “user account” on the irt.insysbio.com.

To get more information on any tool or leave your feedback, please feel free to contact us: support@insysbio.com

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Edinburgh, UK (INSYSBIO UK LIMITED), Limassol, Cyprus (INSYSBIO CY Ltd) and Moscow, Russia (INSYSBIO LLC). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com

September 2025
MoTuWeThFrSaSu
1
2
3
4
5
6
7
8
9
10
1. 10 Sep 2025 15:18 InSysBio to participate in ACoP 2025 InSysBio announces its participation in 2025 American Conference on Pharmacometrics (ACoP 2025) which is to be held from October 18-21, 2025 at the Gaylord Rockies, Aurora, Colorado, USA. InSysBio team is going to present its QSP modeling services & software to optimize drug development at the Booth #11 and 2 posters in frames of the Conference
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
1. 25 Sep 2025 14:12 InSysBio to take part in BioTechX Europe 2025 InSysBio announces its participation in BioTechX Europe 2025 on 6–8 October 2025 at Messe Basel, Switzerland. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, is going to present InSysBio's modeling services for drug research & development at the Booth S62
26
27
28
29
30
1. 30 Sep 2025 16:17 InSysBio to participate in JuliaCon Local Paris 2025 InSysBio announces its participation in JuliaCon Local Paris 2025 which is to be held from October 2-3, 2025 at the National Conservatory of Arts and Crafts, Paris, France. Ivan Borisov, Senior Software Developer at InSysBio, will present a poster in frames of the Conference
     
Upcoming Events
10.08
InSysBio to take part in JuliaCon 2026
Tags
Latest News
10.06
16th InSysBio’s Annual Internal Scientific Meeting
28.01
InSysBio to announce a new collaborative project with BeOne Medicines
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"